Podcast Episodes
Back to Search
Andrew Thake: key trends at Resourcing Tomorrow 2025
Episode 13682
Resourcing Tomorrow divisional director Andrew Thake talked with Proactive's Stephen Gunnion about final preparations for the upcoming Resourcing Tom…
4 months, 4 weeks ago
ImmuPharma CEO confident on P140 partnership as strong pharma interest extends timeline into 2026
Episode 13683
ImmuPharma PLC (AIM:IMM) CEO Tim McCarthy talked with Proactive's Stephen Gunnion about the company's ongoing discussions to secure a partnership for…
4 months, 4 weeks ago
Buccaneer Energy adds acreage at Fouke; CEO details next steps
Episode 13691
Buccaneer Energy Plc (AIM:BUCE) CEO Paul Welch talked with Proactive's Stephen Gunnion about the company’s strategic progress in East Texas, focusing…
4 months, 4 weeks ago
IP Group's Parkwalk Advisors sees scale-up gains from budget reforms
Episode 13680
Susie Harris, director of business development at Parkwalk Advisors, the fund management business of IP Group PLC (LSE:IPO), talked with Proactive's …
4 months, 4 weeks ago
ReElement and SAGINT partner on blockchain tokenization to strengthen critical mineral traceability
Episode 13688
American Resources Corp CEO Mark Jensen joined Steve Darling to announce that the company’s subsidiary, ReElement Technologies, has entered into a To…
5 months ago
Medicus Pharma applies for FDA priority voucher to accelerate SkinJect’s non-invasive BCC therapy
Episode 13687
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce that the company has formally submitted an FDA Commissioner’s Nati…
5 months ago
Standard Uranium wins key permits, launching first drill program at Corvo in more than 40 years
Episode 13679
Standard Uranium Vice President of Exploration Sean Hillacre joined Steve Darling from Proactive to share that the company has received exploration p…
5 months ago
Starpharma highlights major Oncology partnerships and 2026 clinical milestones
Episode 13678
Starpharma CEO Cheryl Maley joined Steve Darling from Proactive to discuss the company’s recent momentum in oncology development and strategic partne…
5 months ago
MustGrow Biologics posts $0.8M in Q3 revenue as NexusBioAg drives margin growth
Episode 13677
MustGrow Biologics Corp Chief Executive Officer Corey Giasson joined Steve Darling from Proactive to discuss the company’s financial results for the …
5 months ago
Bitcoin's decline presents Black Friday buying opportunity, says Bitwise AM European head
Episode 13676
Bitwise Asset Management European head Bradley Duke talked with Proactive's Stephen Gunnion about the recent decline in Bitcoin's price and what it c…
5 months ago